Discover the most talked about and latest scientific content & concepts.

Sublingual Immunotherapy for Allergic Fungal Sinusitis

The Annals of otology, rhinology, and laryngology | 24 Apr 2015

JM Melzer, BR Driskill, TL Clenney and EM Gessler
Allergic fungal sinusitis (AFS) is a condition that has an allergic basis caused by exposure to fungi in the sinonasal tract leading to chronic inflammation. Despite standard treatment modalities, which typically include surgery and medical management of allergies, patients still have a high rate of recurrence. Subcutaneous immunotherapy (SCIT) has been used as adjuvant treatment for AFS. Evidence exists to support the use of sublingual immunotherapy (SLIT) as a safe and efficacious method of treating allergies, but no studies have assessed the utility of SLIT in the management of allergic fungal sinusitis. A record review of cases of AFS that are currently or previously treated with sublingual immunotherapy from 2007 to 2011 was performed. Parameters of interest included serum IgE levels, changes in symptoms, Lund-McKay scores, decreased sensitization to fungal allergens associated with AFS, and serum IgE levels. Ten patients with diagnosed AFS were treated with SLIT. No adverse effects related to the use of SLIT therapy were identified. Decreases in subjective complaints, exam findings, Lund-McKay scores, and serum IgE levels were observed. Thus, sublingual immunotherapy appears to be a safe adjunct to the management of AFS that may improve patient outcomes.
Facebook likes*
News coverage*
SC clicks
Mast cell, Sinusitis, Allergology, Immunology, Immunoglobulin E, Immune system, Asthma, Allergy
MeSH headings
comments powered by Disqus

* Data courtesy of